Indication: Hepatitis C Virus (HCV)

A Long Term Follow-up Registry for Adolescent and Pediatric Subjects Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials

Sub-indication: Hepatitis C Virus (HCV)

Study Type: Registry

Principal Investigator: Victoria A Statler, M.D.
Norton Children's Infectious Diseases, affiliated with the UofL School of Medicine

Sponsor: Sponsor: Gilead Sciences, Inc

Search our entire site.